12:00 AM
 | 
Jun 11, 2012
 |  BC Week In Review  |  Company News  |  Deals

Merus Labs International deal

Merus signed a letter of intent with an undisclosed pharmaceutical company for rights to manufacture and commercialize a branded...

Read the full 74 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >